Levetiracetam: A Nootropic Drug with Unique Properties
Levetiracetam (LEV), also known as Keppra, is a nootropic drug used to treat epilepsy and other neurological disorders. It is a derivative of piracetam, a popular nootropic drug, and is believed to have similar effects on the brain. LEV is thought to improve cognitive function, reduce anxiety, and improve mood. It is also believed to have neuroprotective effects, which may help protect the brain from damage caused by seizures.
Positive Effects of Levetiracetam
- Improves cognitive function
- Reduces anxiety
- Improves mood
- Neuroprotective effects
Possible Negative Effects of Levetiracetam
- Weight gain
The recommended starting dose of LEV is 500 mg twice daily. The dose may be increased by 500 mg every two weeks, up to a maximum of 3000 mg per day. It is important to take LEV exactly as prescribed by your doctor. Do not stop taking LEV without talking to your doctor first.
History of Levetiracetam
Levetiracetam was first developed in the 1970s by UCB Pharma, a Belgian pharmaceutical company. It was approved by the FDA in 1999 for the treatment of epilepsy. Since then, it has been used to treat a variety of neurological disorders, including anxiety, bipolar disorder, and Alzheimer's disease. LEV has become increasingly popular as a nootropic drug, due to its purported cognitive-enhancing effects.